tiprankstipranks
Hikma Pharmaceuticals PLC (HKMPY)
OTHER OTC:HKMPY
US Market
HKMPY
Hikma Pharmaceuticals
RESEARCH TOOLSreports

Hikma Pharmaceuticals (HKMPY) Ratios

44 Followers

Hikma Pharmaceuticals Ratios

HKMPY's free cash flow for Q4 2025 was $0.40. For the 2025 fiscal year, HKMPY's free cash flow was decreased by $ and operating cash flow was $0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.82 1.82 1.14 1.57 1.86
Quick Ratio
 1.06 1.06 0.65 0.90 1.14
Cash Ratio
 0.23 0.23 0.10 0.15 0.25
Solvency Ratio
 0.17 0.20 0.20 0.15 0.16
Operating Cash Flow Ratio
 0.27 0.25 0.29 0.45 0.49
Short-Term Operating Cash Flow Coverage
 3.42 3.16 0.88 4.05 3.81
Net Current Asset Value
$ -422.15M$ -422.00M$ -549.00M$ -371.00M$ -324.00M
Leverage Ratios
Debt-to-Assets Ratio
 0.29 0.29 0.25 0.25 0.29
Debt-to-Equity Ratio
 0.64 0.64 0.57 0.54 0.60
Debt-to-Capital Ratio
 0.39 0.39 0.36 0.35 0.38
Long-Term Debt-to-Capital Ratio
 0.36 0.36 0.21 0.31 0.33
Financial Leverage Ratio
 2.19 2.19 2.22 2.13 2.09
Debt Service Coverage Ratio
 2.53 3.29 0.87 1.98 3.09
Interest Coverage Ratio
 5.31 5.89 6.95 4.22 4.03
Debt to Market Cap
 0.43 0.35 0.23 0.22 0.29
Interest Debt Per Share
 7.98 15.91 12.60 11.49 12.10
Net Debt to EBITDA
 1.97 1.58 1.54 1.76 1.47
Profitability Margins
Gross Profit Margin
41.35%40.04%45.25%48.94%49.19%
EBIT Margin
16.81%18.63%16.95%12.80%19.79%
EBITDA Margin
19.96%24.96%23.25%19.44%27.33%
Operating Profit Margin
16.81%18.63%19.57%12.77%11.20%
Pretax Profit Margin
15.49%15.50%14.52%9.77%9.26%
Net Profit Margin
12.00%12.00%11.48%6.61%7.47%
Continuous Operations Profit Margin
12.15%12.15%11.54%6.68%7.59%
Net Income Per EBT
77.45%77.46%79.07%67.62%80.69%
EBT Per EBIT
92.14%83.17%74.18%76.57%82.62%
Return on Assets (ROA)
7.10%7.11%6.99%4.06%4.20%
Return on Equity (ROE)
15.83%15.54%15.54%8.64%8.81%
Return on Capital Employed (ROCE)
13.38%14.83%19.40%10.98%8.31%
Return on Invested Capital (ROIC)
10.21%11.32%12.78%7.16%6.53%
Return on Tangible Assets
8.95%8.95%9.03%5.31%5.62%
Earnings Yield
10.28%8.71%6.49%3.76%4.55%
Efficiency Ratios
Receivables Turnover
 3.11 3.11 3.46 3.64 3.24
Payables Turnover
 2.75 2.81 4.78 4.75 4.40
Inventory Turnover
 1.78 1.82 1.74 1.65 1.65
Fixed Asset Turnover
 2.32 2.32 2.36 2.52 2.33
Asset Turnover
 0.59 0.59 0.61 0.61 0.56
Working Capital Turnover Ratio
 3.97 4.55 5.98 3.42 2.52
Cash Conversion Cycle
 189.87 188.23 239.53 244.88 251.08
Days of Sales Outstanding
 117.36 117.32 105.64 100.17 112.68
Days of Inventory Outstanding
 205.11 200.57 210.22 221.54 221.45
Days of Payables Outstanding
 132.60 129.66 76.33 76.83 83.05
Operating Cycle
 322.46 317.90 315.85 321.70 334.13
Cash Flow Ratios
Operating Cash Flow Per Share
 1.77 3.26 5.10 5.47 4.74
Free Cash Flow Per Share
 0.88 1.47 2.97 3.63 2.73
CapEx Per Share
 0.89 1.79 2.12 1.83 2.01
Free Cash Flow to Operating Cash Flow
 0.50 0.45 0.58 0.66 0.58
Dividend Paid and CapEx Coverage Ratio
 1.03 0.94 1.38 1.78 1.51
Capital Expenditure Coverage Ratio
 2.00 1.82 2.40 2.98 2.36
Operating Cash Flow Coverage Ratio
 0.24 0.22 0.43 0.51 0.41
Operating Cash Flow to Sales Ratio
 0.12 0.11 0.18 0.21 0.21
Free Cash Flow Yield
5.03%3.51%5.94%8.00%7.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 9.40 11.48 15.42 26.57 21.99
Price-to-Sales (P/S) Ratio
 1.11 1.38 1.77 1.76 1.64
Price-to-Book (P/B) Ratio
 1.46 1.78 2.40 2.30 1.94
Price-to-Free Cash Flow (P/FCF) Ratio
 19.20 28.48 16.82 12.50 13.55
Price-to-Operating Cash Flow Ratio
 9.71 12.85 9.81 8.30 7.80
Price-to-Earnings Growth (PEG) Ratio
 68.09 0.89 0.17 22.32 -0.41
Price-to-Fair Value
 1.46 1.78 2.40 2.30 1.94
Enterprise Value Multiple
 7.55 7.10 9.15 10.80 7.48
Enterprise Value
 5.19B 5.95B 6.65B 6.03B 5.15B
EV to EBITDA
 7.74 7.10 9.15 10.80 7.48
EV to Sales
 1.54 1.77 2.13 2.10 2.04
EV to Free Cash Flow
 26.65 36.62 20.22 14.94 16.87
EV to Operating Cash Flow
 13.30 16.52 11.80 9.93 9.71
Tangible Book Value Per Share
 6.53 13.02 10.53 9.97 9.15
Shareholders’ Equity Per Share
 11.78 23.51 20.87 19.77 19.09
Tax and Other Ratios
Effective Tax Rate
 0.22 0.22 0.20 0.32 0.18
Revenue Per Share
 15.25 30.44 28.26 25.86 22.50
Net Income Per Share
 1.83 3.65 3.24 1.71 1.68
Tax Burden
 0.77 0.77 0.79 0.68 0.81
Interest Burden
 0.92 0.83 0.86 0.76 0.47
Research & Development to Revenue
 0.05 0.05 0.05 0.05 0.06
SG&A to Revenue
 0.20 0.17 0.18 0.22 0.20
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
Income Quality
 2.37 0.89 1.24 2.16 2.27
Currency in USD